Your browser doesn't support javascript.
loading
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.
Morschhauser, Franck; Dyer, Martin J S; Walter, Harriet S; Danilov, Alexey V; Ysebaert, Loic; Hodson, Daniel James; Fegan, Christopher; Rule, Simon A; Radford, John; Cartron, Guillaume; Bouabdallah, Krimo; Davies, Andrew John; Spurgeon, Stephen; Rajakumaraswamy, Nishanthan; Li, Biao; Humeniuk, Rita; Huang, Xi; Bhargava, Pankaj; Jürgensmeier, Juliane M; Salles, Gilles.
Afiliação
  • Morschhauser F; Univ. Lille, CHU Lille, ULR 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France. franck.morchhauser@chru-lille.fr.
  • Dyer MJS; Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, UK.
  • Walter HS; Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, UK.
  • Danilov AV; City of Hope National Medical Center, Duarte, CA, USA.
  • Ysebaert L; Département d'Hématologie IUCT-Oncopole, Toulouse, France.
  • Hodson DJ; WT-MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Fegan C; University Hospital of Wales, Cardiff, UK.
  • Rule SA; University of Plymouth Medical School, Plymouth, UK.
  • Radford J; University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.
  • Cartron G; Department of Clinical Hematology, University Hospital of Montpellier and UMR-CNRS 5535, Montpellier, France.
  • Bouabdallah K; Hematology Clinic, University Hospital of Bordeaux, Pessac, France.
  • Davies AJ; Cancer Research UK Centre, University of Southampton, Southampton, UK.
  • Spurgeon S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Rajakumaraswamy N; Gilead Sciences, Inc, Foster City, CA, USA.
  • Li B; Gilead Sciences, Inc, Foster City, CA, USA.
  • Humeniuk R; Gilead Sciences, Inc, Foster City, CA, USA.
  • Huang X; Gilead Sciences, Inc, Foster City, CA, USA.
  • Bhargava P; Gilead Sciences, Inc, Foster City, CA, USA.
  • Jürgensmeier JM; Gilead Sciences, Inc, Foster City, CA, USA.
  • Salles G; Hospices Civils de Lyon, Department of Hematology, Université de Lyon, Lyon, France.
Leukemia ; 35(7): 2108-2113, 2021 07.
Article em En | MEDLINE | ID: mdl-33328591
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Purinas / Pirazinas / Pirimidinas / Linfoma de Células B / Inibidores de Proteínas Quinases / Quinazolinonas / Imidazóis / Indazóis / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Purinas / Pirazinas / Pirimidinas / Linfoma de Células B / Inibidores de Proteínas Quinases / Quinazolinonas / Imidazóis / Indazóis / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França